期刊文献+

Lymphoma and cerebral vasculitis in association with X-linked lymphoproliferative disease 被引量:1

Lymphoma and cerebral vasculitis in association with X-linked lymphoproliferative disease
下载PDF
导出
摘要 Lymphoma is seen in up to 30%of patients with X-linked lymphoproliferative disease(XLP),but cerebral vasculitis related with XLP after cure of Burkitt lymphoma is rarely reported.We describe a case of a 5-year-old boy with XLP who developed cerebral vasculitis two years after cure of Burkitt lymphoma.He had Burkitt lymphoma at the age of 3 years and received chemotherapy(non-Hodgkin’s lymphomaBerlin-Frankfurt-Milan-90 protocol plus rituximab),which induced complete remission over the following two years.At the age of 5 years,the patient first developed headache,vomiting,and then intellectual and motorial retrogression.His condition was not improved after anti-infection,dehydration,or dexamethasone therapy.No tumor cells were found in his cerebrospinal fluid.Magnetic resonance imaging showed multiple non-homogeneous,hypodense masses along the bilateral cortex.Pathology after biopsy revealed hyperplasia of neurogliocytes and vessels,accompanied by lymphocyte infiltration but no tumor cell infiltration.Despite aggressive treatment,his cognition and motor functions deteriorated in response to progressive cerebral changes.The patient is presently in a vegetative state.We present this case to inform clinicians of association between lymphoma and immunodeficiency and explore an optimal treatment for lymphoma patients with compromised immune system. Lymphoma is seen in up to 30% of patients with X-linked lymphoproliterative disease (XLP), DUt cerebral vasculitis related with XLP after cure of Burkitt lymphoma is rarely reported. We describe a case of a 5-year-old boy with XLP who developed cerebral vasculitis two years after cure of Burkitt lymphoma. He had Burkitt lymphoma at the age of 3 years and received chemotherapy (non-Hodgkin's lymphoma- Berlin-Frankfurt-Milan-90 protocol plus rituximab), which induced complete remission over the following two years. At the age of 5 years, the patient first developed headache, vomiting, and then intellectual and motorial retrogression. His condition was not improved after anti-infection, dehydration, or dexamethasone therapy. No tumor cells were found in his cerebrospinal fluid. Magnetic resonance imaging showed multiple non-homogeneous, hypodense masses along the bilateral cortex. Pathology after biopsy revealed hyperplasia of neurogliocytes and vessels, accompanied by lymphocyte infiltration but no tumor cell infiltration. Despite aggressive treatment, his cognition and motor functions deteriorated in response to progressive cerebral changes. The patient is presently in a vegetative state. We present this case to inform clinicians of association between lymphoma and immunodeficiency and explore an optimal treatment for lymphoma patients with compromised immune system.
出处 《Chinese Journal of Cancer》 SCIE CAS CSCD 2013年第12期673-677,共5页
关键词 淋巴瘤 脑脊液 血管炎 关联性 淋巴组织 疾病 连锁 增生性 Burkitt lymphoma, cerebral vasculitis, X-linked lymphoproliferative disease, Epstein-Barr virus
  • 相关文献

参考文献18

  • 1Rezaei N, Mahmoudi E, Aghamohammadi A, et al. X-linked lymphoproliferative syndrome: a genetic condition typified by the triad of infection, immunodeficiency and lymphoma. Br J Haematol, 2010,152:13-30.
  • 2Purtilo DT, Cassel CK, Yang JP, et al. X-linked recessive progressive combined variable immunodeficiency (Duncan's disease). Lancet, 1975,1:935-940.
  • 3Booth C, Gilmour KC, Veys P, et al. X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on themanifestations, management and outcome of the disease, Blood, 2011,117:53-62.
  • 4Cannons JL, Tangye SG, Schwartzberg PL. SLAM family receptors and SAP adaptors in immunity. Annu Rev Immunol, 2011,29:665- 705.
  • 5Okano M, Gross TG. Epstein-Barr virus-associated hemophagocytic syndrome and fatal infectious mononucleosis. Am J Hematol, 1996,53:111-115.
  • 6Dupre L, Andolfi G, Tangye SG, et al. SAP controls the cytolyticactivity of CD8+ T cells against EBV-infected cells. Blood, 2005,105:4383-4389.
  • 7Sharifi R, Sinclair JC, Gilmour KC, et al. SAP mediates specific eytotoxic T-cell functions in X-linked lymphoproliferative disease. Blood, 2004,103:3821-3827.
  • 8Benoit L, Wang X, Pabst HF, et al. Defective NK cells activation in X-linked lymphoproliferative disease. J Immunol, 2000,165:3549- 3553.
  • 9Nakajima H, Celia M, Bouchon A, et al. Patients with X-linked lymphoproliferative disease have a defect in 2B4 receptor- mediated NK cell cytotoxicity. Eur J Immunol, 2000,30:3309-3318.
  • 10Tangye SG, Phillips JH, Lanier LL, et al. Functional requirement for SAP in 2B4-mediated activation of human natural killer cells as revealed by the X-linked lymphoproliferative syndrome. J Innunol, 2000,165:2932-2936.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部